Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease
林西替尼是一种 IGF-1R 抑制剂,可减缓甲状腺眼病模型中的疾病发展和进展
期刊:Frontiers in Endocrinology
影响因子:
doi:10.3389/fendo.2023.1211473
Anne Gulbins, Mareike Horstmann, Anke Daser, Ulrich Flögel, Michael Oeverhaus, Nikolaos E Bechrakis, J Paul Banga, Simone Keitsch, Barbara Wilker, Gerd Krause, Gary D Hammer, Andrew G Spencer, Ryan Zeidan, Anja Eckstein, Svenja Philipp, Gina-Eva Görtz